| P2093 | author name string | R Thiruvengadam | |
| | J O Atiba | |
| | S H Azawi | |
| P2860 | cites work | Hypercalcaemia due to all-trans retinoic acid | Q28327324 |
| | Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis | Q33488295 |
| | Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation | Q33489400 |
| | Chemotherapy of lung cancer | Q35234264 |
| | Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer | Q40720066 |
| | Regulation of parathyroid hormone-related protein production by a squamous carcinoma cell line in vitro | Q41529343 |
| | Restoration of oral all-trans retinoic acid bioavailability after a brief drug holiday | Q41682095 |
| | Activity of isotretinoin against squamous cell cancers and preneoplastic lesions. | Q42243958 |
| | Phase I/II study of intermittent all-trans-retinoic acid, alone and in combination with interferon alfa-2a, in patients with epidemic Kaposi's sarcoma | Q42277370 |
| | Hypercalcaemia and increased serum interleukin-6 levels induced by all-trans retinoic acid in patients with multiple myeloma | Q42280442 |
| | Hypercalcemia: a dose-limiting toxicity associated with 13-cis-retinoic acid. | Q42286167 |
| | Hypercalcemia associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia | Q42558253 |
| | Hypercalcaemia caused by all-trans retinoic acid treatment of acute promyelocytic leukaemia: case report | Q42562367 |
| | All-trans retinoic acid induced hypercalcemia in a patient with acute promyelocytic leukemia: its relation to increased PTH-rP. | Q42562775 |
| | Hypercalcaemia caused by all-trans retinoic acid (ATRA) treatment in a case of acute promyelocytic leukaemia was manageable after decreasing the ATRA dose to 27 mg/m2/day | Q42567054 |
| | 13-cis-Retinoic Acid and Interferon -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the Skin | Q44083749 |
| | Effect of recombinant monokines, lymphokines, and other agents on clonal proliferation of human lung cancer cell lines. | Q44094537 |
| | 13-cis-Retinoic Acid Plus Interferon -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the Cervix | Q44180324 |
| | Phase II study of isotretinoin in the treatment of advanced non-small cell lung cancer. | Q44494225 |
| | Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule | Q49177717 |
| | Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia | Q54277096 |
| | Leukocytosis associated with all-trans-retinoic acid therapy in metastatic non-small-cell lung cancer | Q67506411 |
| | A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer | Q68857547 |
| | Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group | Q69358817 |
| | Use of a human tumor cloning system to screen retinoids for antineoplastic activity | Q70896296 |
| | Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer | Q72679569 |
| P433 | issue | 4 | |
| P921 | main subject | phase II clinical trial | Q42824440 |
| P304 | page(s) | 395-401 | |
| P577 | publication date | 1996-01-01 | |
| P1433 | published in | Investigational New Drugs | Q2312231 |
| P1476 | title | A phase II trial of a differentiating agent (tRA) with cisplatin-VP 16 chemotherapy in advanced non-small cell lung cancer | |
| P478 | volume | 14 | |